Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medpace Holdings, Inc. - Common Stock
(NQ:
MEDP
)
618.88
+4.82 (+0.78%)
Streaming Delayed Price
Updated: 1:02 PM EDT, Aug 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medpace Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Why Medpace Popped 13% This Week
↗
October 24, 2025
The biopharmaceutical processor posted another strong earnings result for the third quarter.
Via
The Motley Fool
Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings
↗
October 24, 2025
Via
Benzinga
MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook
October 23, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 23.7% year on year to $659.9 million. The company’s full-year...
Via
StockStory
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
↗
October 23, 2025
Medpace shares climb as Q3 earnings and revenue top estimates, driven by strong bookings, rising backlog, and an upbeat 2025 guidance.
Via
Benzinga
Topics
Earnings
Preview: Medpace Hldgs's Earnings
↗
October 21, 2025
Via
Benzinga
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday
↗
October 23, 2025
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 23, 2025
Via
Benzinga
Stock Market Today: Dow Jones, Nasdaq Futures Tumble Amid US-China Trade Tensions—Tesla, IBM, American Airlines In Focus
↗
October 23, 2025
U.S. stock futures were swinging on Thursday following Wednesday’s declines. Futures of major benchmark indices were lower.
Via
Benzinga
Topics
Stocks
MEDPACE HOLDINGS INC (NASDAQ:MEDP) Emerges as a Top Growth and Momentum Pick
↗
October 23, 2025
MEDP Holdings stock shows strong technical and fundamental growth momentum, meeting strict trend-following criteria for a powerful setup.
Via
Chartmill
Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike
↗
October 22, 2025
Medpace stock rocketed late Wednesday on "another strong Q," that included double-digit sales and profit growth.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 22, 2025
Via
Benzinga
Medpace Holdings Inc (NASDAQ:MEDP) Tops Q3 2025 Earnings and Revenue Estimates
↗
October 22, 2025
Medpace (MEDP) Q3 2025 earnings beat analyst forecasts with strong revenue and EPS growth. The CRO also reported robust bookings and raised its full-year guidance.
Via
Chartmill
Topics
Earnings
Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5%
October 22, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 23.7% year on year to $659.9 million. The company’s...
Via
StockStory
Which stocks are moving after the closing bell on Wednesday?
↗
October 22, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Medpace Holdings, Inc. Reports Third Quarter 2025 Results
October 22, 2025
From
Medpace Holdings, Inc.
Via
Business Wire
Medpace (MEDP) Reports Earnings Tomorrow: What To Expect
October 20, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results this Wednesday afternoon. Here’s what to expect.
Via
StockStory
1 High-Flying Stock to Research Further and 2 That Underwhelm
October 17, 2025
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...
Via
StockStory
Topics
Supply Chain
Earnings Scheduled For October 22, 2025
↗
October 22, 2025
Via
Benzinga
1 Volatile Stock Worth Investigating and 2 That Underwhelm
October 13, 2025
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
Via
StockStory
Medpace and Revvity Stocks Trade Down, What You Need To Know
October 10, 2025
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Via
StockStory
Topics
Economy
Government
World Trade
3 Market-Beating Stocks with Competitive Advantages
October 09, 2025
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends...
Via
StockStory
Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)
October 05, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks,...
Via
StockStory
This RH Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
↗
October 02, 2025
Via
Benzinga
Why Medpace (MEDP) Stock Is Trading Lower Today
October 02, 2025
Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 3.2% in the morning session after Barclays downgraded the stock to "Underweight" from "Equal-Weight" and reduced its price...
Via
StockStory
Breaking Down Medpace Hldgs: 10 Analysts Share Their Views
↗
October 02, 2025
Via
Benzinga
1 Healthcare Stock with Exciting Potential and 2 We Ignore
September 29, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...
Via
StockStory
Topics
Stocks
Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025
September 23, 2025
From
Medpace Holdings, Inc.
Via
Business Wire
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
September 15, 2025
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Via
StockStory
Topics
Regulatory Compliance
Medpace Hldgs Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
↗
September 03, 2025
Via
Benzinga
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
↗
September 03, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
